MSD announces the Primary Results of Trial uating Cardiovascular Outcomes with Sitagliptin
MSD, known as Merck in the United States and Canada, has announced the primary results of the Trial uating Cardiovascular […]
DIABETIC-MEDICINE-AND-DIABETES-TRIALS-UNIT
